TFEB and chronic obstructive pulmonary disease: In a cellular model of chronic obstructive pulmonary disease (COPD) emphysema, β-galactosidase activity dropped when cells were treated with gemfibrozil to stimulate TFEB activity, suggesting that TFEB activation could prevent senescence induction.